[1]董明伟.癌性疼痛规范化诊疗中临床药师的药学监护作用[J].医学信息,2020,33(11):151-153.[doi:10.3969/j.issn.1006-1959.2020.11.049]
 DONG Ming-wei.The Pharmacological Monitoring Function of Clinical Pharmacists in the Standardized Diagnosis and Treatment of Cancer Pain[J].Medical Information,2020,33(11):151-153.[doi:10.3969/j.issn.1006-1959.2020.11.049]
点击复制

癌性疼痛规范化诊疗中临床药师的药学监护作用()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年11期
页码:
151-153
栏目:
药物与临床
出版日期:
2020-06-01

文章信息/Info

Title:
The Pharmacological Monitoring Function of Clinical Pharmacists in the Standardized Diagnosis and Treatment of Cancer Pain
文章编号:
1006-1959(2020)11-0151-03
作者:
董明伟
(佳木斯市中心医院药剂科,黑龙江 佳木斯 154002)
Author(s):
DONG Ming-wei
(Department of Pharmacy,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
癌性疼痛规范化诊疗临床药师药学监护
Keywords:
Cancer painStandardized diagnosis and treatmentClinical pharmacistPharmaceutical monitoring
分类号:
R730.5
DOI:
10.3969/j.issn.1006-1959.2020.11.049
文献标志码:
A
摘要:
目的 研究癌性疼痛规范化诊疗中临床药师的药学监护作用。方法 选取2018年6月~2019年6月在我院诊治的124例癌性疼痛患者为研究对象,采用随机数字表法分为对照组和观察组,各62例。对照组采用常规治疗,观察组在对照组基础上给予临床药师药学监护干预,比较两组临床疼痛缓解率、治疗前后疼痛度评分、爆发痛次数、临床行为(遵医嘱用药、合理饮食、情绪稳定、坚持治疗)依从评分、不良反应(恶心、呕吐、腹泻、便秘、手脚麻木)缓解情况。结果 观察组临床缓解率为83.87%,高于对照组的70.96%,差异有统计学意义(P<0.05);治疗后两组疼痛评分、爆发痛次数均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);治疗后观察组遵医嘱用药、合理饮食、情绪稳定依从评分均高于对照组,差异有统计学意义(P<0.05);干预后观察组不良反应缓解率高于对照组,差异有统计学意义(P<0.05)。结论 癌性疼痛规范化诊疗中实施临床药师药学监护干预有助于提高癌性疼痛缓解率,降低疼痛评分,减少爆发痛次数,进一步提高患者临床诊治行为依从性和不良反应缓解率。
Abstract:
Objective To study the pharmacological monitoring function of clinical pharmacists in the standardized diagnosis and treatment of cancer pain.Methods A total of 124 patients with cancer pain diagnosed and treated in our hospital from June 2018 to June 2019 were selected as the research object,using the random number table method to divide into control group and observation group, with 62 cases in each group. The control group was treated with conventional treatment, and the observation group was given a clinicarl pharmacist intervention on the basis of the control group, compared the clinical pain remission rate, pain score before and after treatment, number of outbreaks of pain, compliance score of clinical behavior (taking medicine according to doctor’s advice, rational diet, emotional stability, and persistent treatment), and relief of adverse reactions (nausea, vomiting, diarrhea, constipation, and numbness of hands and feet) between the two groups.Results The clinical remission rate of the observation group was 83.87%, which was higher than that of the control group 70.96%, the difference was statistically significant (P<0.05); after treatment, the pain score and the number of outbreak pain in both groups were lower than before treatment, and the observation group the control group, the difference was statistically significant (P<0.05); after treatment, the observation group followed the doctor ’s instructions for medication, reasonable diet, and emotional stability compliance scores were higher than the control group, the difference was statistically significant (P<0.05); the observation group after intervention remission rate of adverse reactions was higher than that of the control group,the difference was statistically significant (P<0.05).Conclusion The implementation of clinical pharmacist pharmacological monitoring interventions in the standardized diagnosis and treatment of cancer pain can improve the cancer pain relief rate, reduce the pain score, reduce the number of outbreak pain, and further improve the patient’s clinical compliance and adverse reaction relief rate.

参考文献/References:

[1]张兰欣,温泉,王建平,等.临床药师在癌性疼痛管理中的作用[J].中国药房,2015,26(32):4602-4603.[2]刘满英,李志泉,周慧萍,等.对乳腺癌患者实施药学监护效果的临床研究[J].海峡药学,2015,27(11):75-77.[3]谢铮铮,翟所迪,孙路路,等.43例癌痛患者药学监护效果的研究[J].中国医院药学杂志,2012,32(10):799-802.[4]赖瑛,陈红梅,黄伶,等.癌痛规范化治疗示范病房建设中临床药师的工作模式[J].中医药管理杂志,2015,23(10):48-50.[5]许利敏.临床药师在癌痛患者镇痛治疗中的作用与体会[J].中国药房,2015,26(2):262-263.[6]武林鑫,孙莉.癌痛治疗不足的现状与原因[J].肿瘤防治研究,2014,41(4):421-424.[7]许利敏.临床药师在癌痛患者镇痛治疗中的作用与体会[J].中国药房,2015,26(2):262-263.[8]李维筠,郑志恒,关明光.临床药师参与癌痛患者全程治疗的分析[J].中国医药指南,2015,1(20):288-289.[9]万正兰,谢蓉芝,黄燕华.临床药师对住院癌痛患者用药教育模式探讨[J].北方药学,2014,1(12):184-185.[10]曲莉.临床药师对癌痛患者药学监护的策略与方法[J].中国民族民间医药,2015,22(1):45.

相似文献/References:

[1]李 博.盐酸美沙酮片维持治疗难治性癌性疼痛临床观察[J].医学信息,2020,33(08):165.[doi:10.3969/j.issn.1006-1959.2020.08.055]
 LI Bo.Methadone Hydrochloride Tablets Maintain the Therapeutic Effect of Refractory Cancer Pain[J].Medical Information,2020,33(11):165.[doi:10.3969/j.issn.1006-1959.2020.08.055]
[2]贾立永.冰硼散加减外用联合穴位注射治疗原发性肝癌中重度疼痛的临床疗效[J].医学信息,2022,35(06):171.[doi:10.3969/j.issn.1006-1959.2022.06.045]
 JIA Li-yong.Clinical Effect of Modified Bingpeng Powder Combined with Acupoint Injection in the Treatment of Moderate and Severe Pain in Primary Hepatic Carcinoma[J].Medical Information,2022,35(11):171.[doi:10.3969/j.issn.1006-1959.2022.06.045]

更新日期/Last Update: 1900-01-01